Key result
Heparin administration during hemodialysis increased the percent of unbound quinidine from 6.5% at baseline to 12.2%, correlating with a rise in free fatty acids.
Why the study?
Does heparin administration during hemodialysis alter quinidine plasma protein binding in patients with end-stage renal disease?
Observational (n=10)
Does heparin administration during hemodialysis alter quinidine plasma protein binding in patients with end-stage renal disease?
Heparin administration during hemodialysis increases the free fraction of quinidine, suggesting that dynamic changes in free drug levels may require dosage adjustments to avoid toxicity.
Answers are grounded in this paper and cite their sources.
May increase free quinidine during hemodialysis in ESRD; hypothesis-generating and leaves open need for dosing studies before practice change.
Quinidine binding to serum proteins was quantitated in 10 regularly dialyzed patients with end-stage renal disease, both under baseline conditions and after heparin during a single hemodialysis. Quinidine binding was determined in vitro, after the addition of 2 micrograms/ml quinidine sulfate, by ultrafiltration combined with spectrophotofluorometry. The baseline percent unbound quinidine concentration in our patients was 6.5 +/- 2.3% (mean +/- SD), a value lower than in normal subjects (9.9 +/- 3.0%, n = 18, p less than 0.005). Binding correlated with both serum albumin (r = 0.72, p less than 0.02) and free fatty acid (r = 0.65, p less than 0.05) concentrations. After heparin there was a rise in percent unbound quinidine (12.2 +/- 5.6%, p less than 0.025) and in free fatty acid concentration (1111 +/- 1202 microEq/l, p = 0.004) in each subject. After heparin the relationship between quinidine binding and free fatty acid concentration was again evident (r = 0.97, p less than 0.001). Dynamic changes in the levels of free quinidine, as well as other drugs during hemodialysis, may require adjustments to avoid toxicity and adverse interactions.
No takes yet. Share an insight, caveat, or question.
Kessler et al. (1981) conducted an observational in End-stage renal disease (n=10). Heparin during hemodialysis vs. Baseline conditions was evaluated on Percent unbound quinidine concentration (p=<0.025). Heparin administration during hemodialysis increased the percent of unbound quinidine from 6.5% at baseline to 12.2%, correlating with a rise in free fatty acids.
Synapse has enriched 10 related papers. Consider them for comparative context: